See also this year's filing and all EDGAR filings for this company.
PDF Report 0001739426_2023_RVL_Pharmaceuticals_plc.pdf
Logs
Graph
Absolute values for 0001739426, RVL Pharmaceuticals plc
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 56,975,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 69,747,000 |
| 2 | PropertyPlantAndEquipmentNet | 0 |
| 3 | remainder_Assets | 1,788,000 |
| 4 | LiabilitiesCurrent | 19,723,000 |
| 5 | LiabilitiesNoncurrent | 94,000 |
| 6 | remainder_Liabilities | 57,600,000 |
| 7 | CostOfGoodsAndServicesSold | 9,456,000 |
| 8 | SellingGeneralAndAdministrativeExpense | 81,979,000 |
| 9 | ResearchAndDevelopmentExpense | 3,966,000 |
| 10 | remainder_Expenses | 13,290,000 |
| 11 | remainder_Revenues | 49,721,000 |
| 12 | remainder_NetIncome | 7,278,000 |
| 13 | remainder_ComprehensiveNetIncome | -1,700,000 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 128,510,000 |
| 1 | Liabilities | 77,417,000 |
| 2 | Expenses | 108,691,000 |
| 3 | Revenues | 49,721,000 |
| 4 | StockholdersEquity | 51,093,000 |
| 5 | NetIncome | -51,692,000 |
| 6 | ComprehensiveNetIncome | -52,542,000 |
| 7 | BaseVar | 186,658,500 |
| 8 | EconomicCapitalRatio | 0.343 |
Edgar->Model Mapping
Feature Distribution
Change over Time
